Pharmacokinetics and pharmacodynamics of valproate analogs in rats. II. Pharmacokinetics of octanoic acid, cyclohexanecarboxylic acid, and 1‐methyl‐1‐cyclohexanecarboxylic acid
- 1 May 1993
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 14 (4) , 325-339
- https://doi.org/10.1002/bdd.2510140406
Abstract
The pharmacokinetics of valproic acid (VPA) and three structural analogs, octanoic acid (OA), cyclohexanecarboxylic acid (CCA), and 1‐methyl‐1‐cyclohexanecarboxylic acid (MCCA), were examined in female Sprague‐Dawley rats. All four carboxylic acids evidenced dose‐dependent disposition. A dose‐related decrease in total body clearance was observed for each test compound, suggesting the presence of saturable elimination processes. Furthermore, the apparent volume of distribution for these compounds was, with the exception of CCA, dose‐dependent, indicating that binding to proteins in serum and/or tissues may be saturable. Both VPA and MCCA exhibited enterohepatic recirculation, although the degree of recirculation appeared to be dose‐ and compound‐dependent. Significant quantities of both VPA and MCCA were excreted in the urine as base‐labile conjugates, presumably representing glucuronides. In contrast, OA and CCA were not excreted in the urine as base‐labile conjugates and did not evidence enterohepatic recirculation. CCA displayed apparent Michaelis‐Menten kinetics, although the calculated Km was dose‐dependent. The results suggest that relatively minor changes in chemical structure have a marked influence on the metabolism and disposition of low molecular weight carboxylic acids.Keywords
This publication has 21 references indexed in Scilit:
- Physiologic and metabolic influences on enterohepatic recirculation: Simulations based upon the disposition of valproic acid in the ratJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Pharmacokinetics and Pharmacodynamics of Valproate Analogues in Rats. I. Spiro[4.6]Undecane-2-Carboxylic AcidEpilepsia, 1990
- Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure—Pharmacokinetic relationshipsJournal of Pharmacokinetics and Biopharmaceutics, 1988
- Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acidBiochemical and Biophysical Research Communications, 1985
- Controlled and Comparative Trials of Valproate Performed in Europe and AsiaEpilepsia, 1984
- Drug Interactions with Valproic AcidDrugs, 1982
- Clinical Pharmacokinetics of Valproic Acid1Clinical Pharmacokinetics, 1980
- Reye-like syndrome associated with valproic acid therapyThe Journal of Pediatrics, 1979
- Acute Hepatic Failure Associated with the Use of Sodium ValproateNew England Journal of Medicine, 1979
- Sodium ValproateDrugs, 1977